Published in Nature on April 18, 1991
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J (1991) 6.08
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J (1993) 3.74
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63
Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J Virol (1993) 2.69
The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J (1993) 2.49
Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J (1991) 2.39
Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27
Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J Virol (1992) 2.26
An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol (1994) 2.26
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol (1996) 2.01
NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci U S A (1998) 1.92
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A (1993) 1.84
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev (1995) 1.63
The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol Cell Biol (1994) 1.54
T cell activation and disease severity in HIV infection. Clin Exp Immunol (1993) 1.53
The regulation of protein transport to the nucleus by phosphorylation. Biochem J (1995) 1.52
Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci U S A (1996) 1.48
The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains. Nucleic Acids Res (1992) 1.36
Inducible processing of interferon regulatory factor-2. Mol Cell Biol (1992) 1.29
p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol (1992) 1.24
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrob Agents Chemother (1992) 1.24
BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol Cell Biol (1994) 1.22
Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J Virol (1995) 1.21
Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J Virol (1992) 1.21
NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc Natl Acad Sci U S A (1992) 1.18
Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells. J Virol (1992) 1.15
Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation. Infect Immun (1997) 1.09
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers. J Virol (1995) 1.04
Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells. J Virol (1993) 1.03
Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp Med (1992) 1.01
Toxin-based therapeutic approaches. Toxins (Basel) (2010) 1.00
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. Protein Sci (1993) 0.99
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am J Pathol (1993) 0.98
Negative regulation of human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer. Proc Natl Acad Sci U S A (1991) 0.93
NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol (1993) 0.92
Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii. Infect Immun (1998) 0.89
Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation. J Virol (1996) 0.88
Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity. Antimicrob Agents Chemother (2001) 0.88
A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity. Nucleic Acids Res (1996) 0.86
Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation. J Virol (2003) 0.85
Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus. Proc Natl Acad Sci U S A (1991) 0.84
The nfkb1 promoter is controlled by proteins of the Ets family. Mol Biol Cell (1997) 0.84
Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance. Structure (2009) 0.83
Autoprocessing: an essential step for the activation of HIV-1 protease. Biochem J (1996) 0.82
HIV-2 Protease resistance defined in yeast cells. Retrovirology (2006) 0.82
Moloney murine leukemia virus activates NF-kappa B. J Virol (1996) 0.80
Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway. Biochem J (1999) 0.79
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets. Viruses (2014) 0.79
Complex functional interactions at the early enhancer of the PQ strain of BK virus. J Virol (1994) 0.77
Translation initiation of the HIV-1 mRNA. Translation (Austin) (2014) 0.76
In silico prediction of mutant HIV-1 proteases cleaving a target sequence. PLoS One (2014) 0.76
A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol (1981) 9.51
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell (1990) 9.37
Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc Natl Acad Sci U S A (1979) 7.24
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48
A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell (2000) 5.53
Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell (1986) 5.39
The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A (1993) 4.97
The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A (1998) 3.99
Optimal conditions for directly sequencing double-stranded PCR products with sequenase. Nucleic Acids Res (1990) 3.90
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
The precursor of NF-kappa B p50 has I kappa B-like functions. Cell (1992) 3.82
NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci (1992) 3.81
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes. Proc Natl Acad Sci U S A (1987) 3.80
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Insertion of a rabbit beta-globin gene sequence into an E. coli plasmid. Nucleic Acids Res (1975) 3.66
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61
T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today (1995) 3.60
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
Isolation by molecular cloning of a fragment in the split ovalbumin gene. Nature (1978) 3.40
Molecular cloning of extensive sequences of the in vitro synthesized chicken ovalbumin structural gene. Nucleic Acids Res (1977) 3.32
Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes. J Immunol (2000) 3.14
The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J (1992) 2.86
Screening of cloned recombinant DNA in bacteria by in situ colony hybridization. Nucleic Acids Res (1978) 2.85
Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity (2000) 2.71
Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J (1993) 2.71
Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J (1987) 2.71
Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem (2001) 2.71
Peptide chemotaxis in E. coli involves the Tap signal transducer and the dipeptide permease. Nature (1986) 2.66
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65
Methods for identification of recombinants of phage lambda. Proc Natl Acad Sci U S A (1976) 2.51
Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J (1991) 2.39
The ovalbumin gene region: common features in the organisation of three genes expressed in chicken oviduct under hormonal control. Nature (1979) 2.35
I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J (1997) 2.26
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21
Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant. EMBO J (1991) 2.15
Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med (1998) 2.13
N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Mol Cell Biol (1995) 2.12
Electron microscopy and restriction enzyme mapping reveal additional intervening sequences in the chicken ovalbumin split gene. Cell (1978) 2.08
Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. Genes Dev (1994) 2.08
Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol (2000) 2.05
I kappa B proteins: structure, function and regulation. Semin Cancer Biol (1997) 2.01
Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity (1998) 2.00
Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest (1999) 1.91
IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J (1997) 1.91
Structure of C-terminal half of two H-2 antigens from cloned mRNA. Nature (1981) 1.90
cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. Proc Natl Acad Sci U S A (1981) 1.90
Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature (1982) 1.88
Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J Immunol (1989) 1.87
Multiple sequences related to classical histocompatibility antigens in the mouse genome. Nature (1981) 1.87
Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med (2001) 1.86
A cDNA clone containing the entire coding sequence of a mouse H-2Kd histocompatibility antigen. Nucleic Acids Res (1983) 1.86
Studies of the messenger RNA of bacteriophage lambda, I. Various species synthesized early after induction of the prophage. Proc Natl Acad Sci U S A (1968) 1.85
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol (1997) 1.84
Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. Nucleic Acids Res (1982) 1.83
Synthesis of an ovalbumin-like protein by Escherichia coli K12 harbouring a recombinant plasmid. Nature (1978) 1.82
Structure and expression of the mouse beta 2-microglobulin gene isolated from somatic and non-expressing teratocarcinoma cells. EMBO J (1983) 1.82
DNA-DNA hybridization on filters at low temperature in the presence of formamide or urea. Biochimie (1971) 1.80
Lysogenization by bacteriophage lambda. III. Multiplicity dependent phenomena occuring upon infection by lambda. Biochimie (1974) 1.79
The regulation and expression of MHC class I genes. Immunol Today (1990) 1.76
Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol (1992) 1.75
Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell (1987) 1.74
Lysogenization by bacteriophage lambda. I. Multiple infection and the lysogenic response. Mol Gen Genet (1973) 1.72
Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med (1994) 1.63
Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci U S A (1992) 1.62
Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res (1993) 1.62
Hybridization of filters with competitor DNA in the liquid phase in a standard and a micro-assay. Biochimie (1974) 1.60
Expression of class I genes in the major histocompatibility complex: identification of eight distinct mRNAs in DBA/2 mouse liver. Cell (1985) 1.57
Molecular cloning of the genome of poliovirus type 1. Proc Natl Acad Sci U S A (1981) 1.56
SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase. EMBO J (2000) 1.55
Working principles in the immune system implied by the "peptidic self" model. Proc Natl Acad Sci U S A (1987) 1.55
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet (2001) 1.54
T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol (1995) 1.44
T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein. Eur J Immunol (1988) 1.43
Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells. Nucleic Acids Res (1989) 1.41
Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med (2000) 1.38
Oligoclonal repertoire of the CD8 alpha alpha and the CD8 alpha beta TCR-alpha/beta murine intestinal intraepithelial T lymphocytes: evidence for the random emergence of T cells. J Exp Med (1994) 1.36
Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci U S A (2000) 1.34
Siah-1 binds and regulates the function of Numb. Proc Natl Acad Sci U S A (2001) 1.33
Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J Biol Chem (2000) 1.32
Processing of complex heteroduplexes in Escherichia coli and Cos-1 monkey cells. Proc Natl Acad Sci U S A (1984) 1.30
Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors. J Biol Chem (2001) 1.30
Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes. J Biol Chem (1998) 1.27
Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol (1994) 1.27